The transcription factor IRF4 acts as a 'rheostat' for TCR signaling. Discrete levels of IRF4 can activate distinct transcriptional programs in T cells due to binding sites of variable affinity in groups of target genes.
References
Zehn, D., King, C., Bevan, M.J. & Palmer, E. Cell. Mol. Life Sci. 69, 1565–1575 (2012).
Iwata, A. et al. Nat. Immunol. 18, 563–572 (2017).
Schraml, B.U. et al. Nature 460, 405–409 (2009).
Betz, B.C. et al. J. Exp. Med. 207, 933–942 (2010).
Tussiwand, R. et al. Nature 490, 502–507 (2012).
Murphy, T.L., Tussiwand, R. & Murphy, K.M. Nat. Rev. Immunol. 13, 499–509 (2013).
Huber, M. & Lohoff, M. Eur. J. Immunol. 44, 1886–1895 (2014).
Freedman, M.L. et al. Nat. Genet. 43, 513–518 (2011).
Mayya, V. & Dustin, M.L. Trends Immunol. 37, 513–522 (2016).
Tkach, K. & Altan-Bonnet, G. Curr. Opin. Immunol. 25, 120–125 (2013).
Buchholz, V.R. et al. Science 340, 630–635 (2013).
Gerlach, C. et al. Science 340, 635–639 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gallagher, M., Berg, L. Gene-enhancer variants reveal diverse TCR-mediated differentiation. Nat Immunol 18, 483–484 (2017). https://doi.org/10.1038/ni.3729
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3729
- Springer Nature America, Inc.